FDA Approval for Generic Nilotinib for Tasigna

January 1, 2024

Nilotinib is used to treat a type of blood cancer called Philadelphia chromosome positive chronic myeloid leukemia (CML) in adults and children who are at least 1 year old. Nilotinib is usually taken every 12 hours on an empty stomach.

Nilotinib can cause a serious heart problem, especially if you use certain other medicines at the same time. Nilotinib is usually given after other treatments have failed.

Read more…

Related News

demo-attachment-261-Group-56
demo-attachment-606-Group-43
demo-attachment-1121-Rectangle-602

Benefit Advisors & Employees - Want to know more?

Members: Please call the number on the back of your ID card or e-mail member.services@benecardpbf.com Clients: Contact your Client Relations Manager
demo-attachment-180-Group-4